
These phase 3 EXCALIBER-RRMM findings build on earlier MRD-negative complete response results supporting FDA approval of the iberdomide-based regimen.
The American Journal of Managed Care
In the article by Szpunar et al (Am J Manag Care. 2007;13[pt1]:313-315), the e-mail address listed for Dr Szpunar was incorrect. The correct e-mail address is: susan.szpunar@stjohn.org.
over 19 years ago
Liu et al (Am J Manag Care. 2007;13[suppl 3]:S80)over 19 years ago
Effect of Cost-sharing Changes on Self-monitoring of Blood Glucose




